Studies have shown that the CHK1 inhibitor MK-8776 can significantly increase the sensitivity of leukemia cells to histone deacetylase inhibitors by disrupting the mechanisms of DNA replication and DNA repair, including FLT3-ITD + leukemia cells16. Here, FLT3 is linked to leukemia.